Abstract:Carss, K. J., Deaton, A. M., Del Rio-Espinola, A., Diogo, D., Fielden, M., Kulkarni, D. A., et al. (2023). Using human genetics to improve safety assessment of therapeutics. Nat. Rev. Drug Discov. 22, 145–162. doi: 10.1038/s41573-022-00561-w 10.1038/s41573-022-00561-wSearch in Google Scholar PubMed Cipriani, V., Vestito, L., Magavern, E. F., Jacobsen, J. O., Arno, G., Behr, E. R., et al. (2023). Rare disease gene association discovery from burden analysis of the 100 000 Genomes Project data. 2023.12.20.23300294. doi: 10.1101/2023.12.20.23300294 10.1101/2023.12.20.23300294Search in Google Scholar PubMed PubMed Central Dhandapany, P. S., Sadayappan, S., Xue, Y., Powell, G. T., Rani, D. S., Nallari, P., et al. (2009). A common MYBPC3 (cardiac myosin binding protein C) variant associated with cardiomyopathies in South Asia. Nat. Genet. 41, 187–191. doi: 10.1038/ng.309 10.1038/ng.309Search in Google Scholar PubMed PubMed Central Dingemans, A. J. M., Hinne, M., Truijen, K. M. G., Goltstein, L., Reeuwijk, J. van, Leeuw, N. de, et al. (2022). PhenoScore: AI-based phenomics to quantify rare disease and genetic variation. 2022.10.24.22281480. doi: 10.1101/2022.10.24.22281480 10.1101/2022.10.24.22281480Search in Google Scholar Dingemans, A. J. M., Jansen, S., Reeuwijk, J. van, Leeuw, N. de, Pfundt, R., Schuurs-Hoeijmakers, J., et al. (2023). PhenomAD-NDD: the Phenomics Aggregation Database of comorbidities in 51,227 pediatric individuals with NeuroDevelopmental Disorders. 2023.11.29.23299167. doi: 10.1101/2023.11.29.23299167 10.1101/2023.11.29.23299167Search in Google Scholar Jaramillo Oquendo, C., Wai, H. A., Rich, W., Bunyan, D. J., Thomas, N. S., Hunt, D., et al. (2023). RNA sequencing uplifts diagnostic rate in undiagnosed rare disease patients. 2023.07.05.23292254. doi: 10.1101/2023.07.05.23292254 10.1101/2023.07.05.23292254Search in Google Scholar Karczewski, K. J., Gupta, R., Kanai, M., Lu, W., Tsuo, K., Wang, Y., et al. (2024). Pan-UK Biobank GWAS improves discovery, analysis of genetic architecture, and resolution into ancestry-enriched effects. 2024.03.13.24303864. doi: 10.1101/2024.03.13.24303864 10.1101/2024.03.13.24303864Search in Google Scholar Kumar, R., Corbett, M. A., Smith, N. J. C., Hock, D. H., Kikhtyak, Z., Semcesen, L. N., et al. (2022). Oligonucleotide correction of an intronic TIMMDC1 variant in cells of patients with severe neurodegenerative disorder. Npj Genomic Med. 7, 1–12. doi: 10.1038/s41525-021-00277-7 10.1038/s41525-021-00277-7Search in Google Scholar PubMed PubMed Central Luo, X., Sun, Y., Xu, F., Guo, J., Li, L., Lin, Z., et al. (2020). A pilot study of expanded newborn screening for 573 genes related to severe inherited disorders in China: results from 1,127 newborns. Ann. Transl. Med. 8, 1058. doi: 10.21037/atm-20-1147 10.21037/atm-20-1147Search in Google Scholar PubMed PubMed Central Nurk, S., Koren, S., Rhie, A., Rautiainen, M., Bzikadze, A. V., Mikheenko, A., et al. (2022). The complete sequence of a human genome. Science 376, 44–53. doi: 10.1126/science.abj6987 10.1126/science.abj6987Search in Google Scholar PubMed PubMed Central Porubsky, D., Harvey, W. T., Rozanski, A. N., Ebler, J., Höps, W., Ashraf, H., et al. (2023). Inversion polymorphism in a complete human genome assembly. Genome Biol. 24, 100. doi: 10.1186/s13059-023-02919-8 10.1186/s13059-023-02919-8Search in Google Scholar PubMed PubMed Central Posey, J. E. (2019). Genome sequencing and implications for rare disorders. Orphanet J. Rare Dis. 14, 153. doi: 10.1186/s13023-019-1127-0 10.1186/s13023-019-1127-0Search in Google Scholar PubMed PubMed Central Singh, T., Poterba, T., Curtis, D., Akil, H., Al Eissa, M., Barchas, J. D., et al. (2022). Rare coding variants in ten genes confer substantial risk for schizophrenia. Nature 604, 509–516. doi: 10.1038/s41586-022-04556-w 10.1038/s41586-022-04556-wSearch in Google Scholar PubMed PubMed Central <span class="reference-mixed-c -Abstract Truncated-

Pharmacogenetic influences on the response to pharmacological treatment in autism spectrum disorders

Animal models of autism: a perspective from autophagy mechanisms

Pharmacogenetic intervention in the Child and Adolescent Autism Day Therapeutic Unit

Autism genetics: opportunities and challenges for clinical translation

Chromodomain helicase DNA-binding proteins and neurodevelopmental disorders

Clinical Utility and Implementation of Pharmacogenomics for the Personalisation of Antipsychotic Treatments

Pharmacogenomics and Personalized Medicine

Pharmacogenomics: A Genetic Approach to Drug Development and Therapy

A Narrative Review on Pharmacogenomics in Psychiatry: Scientific Definitions, Principles, and Practical Resources

Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions

[Selection of pharmacogenomic variants and methodology for their use in community pharmacy]

Pharmacogenomics and non-genetic factors affecting drug response in autism spectrum disorder in Thai and other populations: current evidence and future implications

Exploring genetic testing requests, genetic alterations and clinical associations in a cohort of children with autism spectrum disorder

Pharmacogenomic insights in psychiatric care: uncovering novel actionability, allele-specific CYP2D6 copy number variation, and phenoconversion in 15,000 patients

Impact of Pharmacogenetic Testing on Clozapine Treatment Efficacy in Patients with Treatment-Resistant Schizophrenia

Synthesis of genetic association studies on autism spectrum disorders using a genetic model-free approach

Decoding the genetic landscape of autism: A comprehensive review

Tagungsbericht Genomics of Rare Disease 2024 Conference

An Update on Psychopharmacological Treatment of Autism Spectrum Disorder

Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms

New Strategies for Clinical Trials in Autism Spectrum Disorder